FDA Orphan Drug Designation 101 James H. Reese, PhD, RAC Health Science Administrator Office of
FDA Orphan Drug Designation 101 James H. Reese, PhD, RAC Health Science Administrator Office of Orphan Products Development (OOPD) Food and Drug Administration (FDA) Worldwide Orphan Medicinal Designation Workshop March 10, 2014 1 Overview
810 views • 36 slides